Prostate Cancer - Results from #23140

Daily life and life quality 3 years following prostate cancer treatment - Abstract May 23, 2013

Receipt of National Comprehensive Cancer Network guideline-concordant prostate cancer care among African American and Caucasian American men in North Carolina - Abstract May 23, 2013

Perceptions of prostate cancer fatalism and screening behavior between United States-born and Caribbean-born Black males - Abstract May 23, 2013

Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer - Abstract May 23, 2013

A randomised, wait-list controlled trial: Evaluation of a cognitive-behavioural group intervention on psycho-sexual adjustment for men with localised prostate cancer - Abstract May 23, 2013

Importance and determinants of Gleason score undergrading on biopsy sample of prostate cancer in a population-based study - Abstract May 23, 2013

High-resolution ERG-expression profiling on GeneChip exon 1.0 ST arrays in primary and castration-resistant prostate cancer - Abstract May 23, 2013

Cost-effectiveness analysis comparing degarelix with leuprolide in hormonal therapy for patients with locally advanced prostate cancer - Abstract May 23, 2013

Salvage intensity modulated radiotherapy using endorectal balloon after radical prostatectomy: Clinical outcomes - Abstract May 23, 2013

BJUI Mini Reviews - Current role of diethylstilbestrol in the management of advanced prostate cancer May 23, 2013

Response to the U.S. Preventative Services Task Force decision on prostate cancer screening - Abstract May 22, 2013

MRI-guided biopsy for prostate cancer detection: A systematic review of current clinical results - Abstract May 22, 2013

Docetaxel chemotherapy for Chinese patients with castrate-resistant prostate cancer - Abstract May 22, 2013

Germline BRCA mutations are associated with higher risk of nodal involvement, distant metastasis, and poor survival outcomes in prostate cancer - Abstract May 22, 2013

Impact of age at diagnosis on outcomes in men with castrate-resistant prostate cancer (CRPC) - Abstract May 22, 2013

Prognostic significance of patterns of seminal vesicle invasion in prostate cancer - Abstract May 22, 2013

Stereotactic body radiotherapy with a focal boost to the MRI-visible tumor as monotherapy for low- and intermediate-risk prostate cancer: Early results - Abstract May 22, 2013

New players for advanced prostate cancer and the rationalisation of insulin-sensitising medication - Abstract May 22, 2013

Review of the economic evaluations of hormonal therapy for patients with locally advanced prostate cancer - Abstract May 22, 2013

Phase III, randomized, placebo-controlled study of docetaxel in combination with zibotentan in patients with metastatic castration-resistant prostate cancer - Abstract May 22, 2013

Page 1158 of 1436